Searched for
VI CEPHALOSPORIN
- Aurobindo Pharma: Gaining from lifting of import alert by US FDAThe lifting of import alert by the US FDA at the manufacturing unit of Aurobindo Pharma led to the drug co's stock closing 11.7% higher.
USFDA lifts import alert on Aurobindo Pharma's Hyderabad facilityUSFDA has lifted the import alert for non-sterile products manufactured at Unit-VI cephalosporin facility based in Hyderabad.- Aurobindo Pharma's sales fall by 7.36% in Q4 FY12, incurs Rs 124 crore loss for FY12Aurobindo Pharma profits dipped considerably to Rs 108 crore, falling by 13.6% compared to the previous year's numbers in the same period.
- Aurobindo Pharma posts Rs 80.16 cr loss in Q2Aurobindo Pharma today posted a consolidated net loss of Rs 80.16 crore for the second quarter ended September 30, 2011.
- Aurobindo Pharma posts net loss of Rs 122.80 cr in Q1The company had reported a net profit of Rs 51.50 crore for the same period previous fiscal, Aurobindo Pharma said in a statement.
- Aurobindo Pharma receives warning letter from USFDA; stock over 9 pc downAurobindo Pharma said it has received a warning letter from the USFDA with regard to its antibiotics manufacturing unit in Hyderabad.
- Aurobindo Pharma receives warning letter from USFDAAurobindo Pharma today said it has received a warning letter from the US health regulator with regard to its antibiotics manufacturing unit...
- Aurobindo to suffer $2-mn loss per month due to USFDA banAurobindo Pharma said they may incur a revenue loss to the extent of $2 million per month till the issue remains unresolved.
Load More- Aurobindo Pharma posts Rs 80.16 cr loss in Q2